TransMedics Group, Inc.

NasdaqGM:TMDX Lagerbericht

Marktkapitalisierung: US$4.8b

TransMedics Group Management

Management Kriterienprüfungen 4/4

TransMedics Group's CEO ist Waleed Hassanein , ernannt in Aug 1998, hat eine Amtszeit von 26.08 Jahren. Die jährliche Gesamtvergütung beträgt $6.76M , bestehend aus 9.4% Gehalt und 90.6% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 1.41% der Aktien des Unternehmens, im Wert von $78.88M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.5 Jahre bzw. 11.1 Jahre.

Wichtige Informationen

Waleed Hassanein

Geschäftsführender

US$6.8m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts9.4%
Amtszeit als Geschäftsführer26.1yrs
Eigentum des Geschäftsführers1.4%
Durchschnittliche Amtszeit des Managements7.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder11.1yrs

Jüngste Management Updates

Recent updates

Returns Are Gaining Momentum At TransMedics Group (NASDAQ:TMDX)

Sep 18
Returns Are Gaining Momentum At TransMedics Group (NASDAQ:TMDX)

TransMedics: Take Profits While The Valuation Is Sky High

Sep 18

TransMedics: Wide Moat Player At A Lower Valuation Than Peers

Sep 10

TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S Is Still On The Mark Following 25% Share Price Bounce

Aug 28
TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S Is Still On The Mark Following 25% Share Price Bounce

TransMedics: Heart And Lungs Will Drive The Next Leg Higher

Aug 19

Analysts Just Made A Meaningful Upgrade To Their TransMedics Group, Inc. (NASDAQ:TMDX) Forecasts

Aug 06
Analysts Just Made A Meaningful Upgrade To Their TransMedics Group, Inc. (NASDAQ:TMDX) Forecasts

TransMedics Group: Providing Long-Term Detailed Forecast And Upgrading To Buy

Aug 04

TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next

Aug 02
TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next

TransMedics Group Stock: Too Far, Too Fast

Jul 08

TransMedics: NOP, Logistics And Transport Are Key Growth Drivers But Stock Is Pricey

Jun 17

TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger

Jun 10
TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger

TransMedics: Transportation Supporting Growth

May 21

TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)

May 06

TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Apr 24
TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

TransMedics Group: Founder Led Company With Solid Potential

Apr 19

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Apr 11
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway

Mar 19

TransMedics Group: Huge Opportunity In Organ Transplants

Mar 12

TransMedics: A Very Expensive Growth Stock

Feb 07

With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For

Jan 23
With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For

Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Jan 02
Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?

Nov 05
Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?

This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year

Aug 06
This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year

TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?

Aug 02
TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?

TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing

Jun 29
TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing

Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts

May 06
Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Apr 27
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Apr 09
Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?

Jan 16
Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Waleed Hassanein im Vergleich zu den Einnahmen von TransMedics Group verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2024n/an/a

US$3m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$7mUS$634k

-US$25m

Sep 30 2023n/an/a

-US$36m

Jun 30 2023n/an/a

-US$18m

Mar 31 2023n/an/a

-US$28m

Dec 31 2022US$3mUS$575k

-US$36m

Sep 30 2022n/an/a

-US$42m

Jun 30 2022n/an/a

-US$48m

Mar 31 2022n/an/a

-US$47m

Dec 31 2021US$7mUS$535k

-US$44m

Sep 30 2021n/an/a

-US$38m

Jun 30 2021n/an/a

-US$30m

Mar 31 2021n/an/a

-US$28m

Dec 31 2020US$2mUS$534k

-US$29m

Sep 30 2020n/an/a

-US$32m

Jun 30 2020n/an/a

-US$35m

Mar 31 2020n/an/a

-US$36m

Dec 28 2019US$3mUS$449k

-US$34m

Sep 28 2019n/an/a

-US$32m

Jun 29 2019n/an/a

-US$29m

Mar 30 2019n/an/a

-US$26m

Dec 29 2018US$524kUS$384k

-US$24m

Sep 29 2018n/an/a

-US$21m

Jun 30 2018n/an/a

-US$20m

Mar 31 2018n/an/a

-US$20m

Dec 30 2017US$601kUS$351k

-US$21m

Vergütung im Vergleich zum Markt: WaleedDie Gesamtvergütung ($USD6.76M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD6.70M).

Entschädigung vs. Einkommen: WaleedDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Waleed Hassanein (56 yo)

26.1yrs

Amtszeit

US$6,758,070

Vergütung

Dr. Waleed H. Hassanein, M.D. is the Founder of Transmedics Group, Inc. and has been its President, Chief Executive Officer and Director since August 1998. He Founded TransMedics, Inc. in August 1998 and h...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Waleed Hassanein
Founder26.1yrsUS$6.76m1.41%
$ 67.9m
Stephen Gordon
CFO, Treasurer & Secretary9.5yrsUS$2.64m0.064%
$ 3.1m
Nicholas Corcoran
Senior Vice President of Supply Chain & Operations1.7yrsUS$2.52m0.0097%
$ 465.8k
Anil Ranganath
Senior VP1.2yrsUS$2.35m0.027%
$ 1.3m
Tamer Khayal
Chief Commercial Officer18.7yrsUS$2.63m0.062%
$ 3.0m
Miriam Provost
Vice President of Global Regulatory Affairs5.3yrsUS$813.47kkeine Daten

7.4yrs

Durchschnittliche Betriebszugehörigkeit

56yo

Durchschnittliches Alter

Erfahrenes Management: Das Managementteam von TMDX ist erfahren und erfahren (durchschnittliche Amtszeit: 5.1 Jahre).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Waleed Hassanein
Founder26.1yrsUS$6.76m1.41%
$ 67.9m
Edwin Kania
Independent Director21.7yrsUS$220.28k0.91%
$ 44.0m
Merilee Raines
Independent Director3.7yrsUS$238.62k0.0036%
$ 172.6k
James Tobin
Independent Chairman13.7yrsUS$262.32k0.52%
$ 25.2m
Edward Zavala
Member of Advisory Boardno datakeine Datenkeine Daten
Gayle Winters
Member of Advisory Boardno datakeine Datenkeine Daten
Ryszard Smolenski
Member of Advisory Boardno datakeine Datenkeine Daten
Bruce Rosengard
Member of Advisory Boardno datakeine Datenkeine Daten
Scott D. Solomon
Member of Advisory Boardno datakeine Datenkeine Daten
Robert Kormos
Member of Advisory Boardno datakeine Datenkeine Daten
Edward Basile
Independent Director8.6yrsUS$232.26k0.0022%
$ 105.6k
Thomas Gunderson
Independent Director8.1yrsUS$237.74k0.0036%
$ 172.6k

11.1yrs

Durchschnittliche Betriebszugehörigkeit

70.5yo

Durchschnittliches Alter

Erfahrener Vorstand: TMDXDie Vorstandsmitglieder sind sehr erfahren ( 10.8 ).